logo
Select company
Select metric
15.74%Inventory to Assets Ratio
VS
Market
15
Sector
9
Industry
3
History
85
$ 7.33Close
$ 3.43 - $ 14.41 52-Week Range
Ticker Information

Ticker

NAGE

Company Name

NIAGEN BIOSCIENCE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NIAGEN BIOSCIENCE INC - Inventory to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NAGE - Inv. to Assets Historical data
DateTotal AssetsInventoryInventory to Assets Ratio
6/30/2025$ 91.53M$ 14.41M15.74%
3/31/2025$ 81.34M$ 11.19M13.75%
12/31/2024$ 68.28M$ 9.19M13.46%
9/30/2024$ 56.52M$ 10.54M18.65%
6/30/2024$ 54.03M$ 11.51M21.3%
3/31/2024$ 54.08M$ 12.49M23.11%
12/31/2023$ 54.96M$ 14.53M26.43%
9/30/2023$ 53.48M$ 12.62M23.6%
6/30/2023$ 53.17M$ 11.97M22.52%
3/31/2023$ 53.77M$ 11.91M22.15%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NIAGEN BIOSCIENCE INC's latest trailing twelve months (TTM) Inv. to Assets stands at 29.48%.
  • Over the past 5 years, NIAGEN BIOSCIENCE INC's average Inv. to Assets has been 23.31%.
  • The median Inv. to Assets for NIAGEN BIOSCIENCE INC during this period was 22.81%
  • NIAGEN BIOSCIENCE INC reached its highest Inv. to Assets over the past 5 years at 34.24%.
  • The lowest Inv. to Assets recorded by NIAGEN BIOSCIENCE INC in the same timeframe 13.46%

NIAGEN BIOSCIENCE INC's Inv. to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Inv. to Assets Benchmarks
CompanyInv. to Assets
CRMD : CORMEDIX INC 3.81%PHAT : PHATHOM PHARMACEUTICALS INC 11.23%GYRE : GYRE THERAPEUTICS INC 5.8%ANAB : ANAPTYSBIO INC 0%ZYME : ZYMEWORKS INC 0%URGN : UROGEN PHARMA LTD 3.42%NRIX : NURIX THERAPEUTICS INC 0%TBPH : THERAVANCE BIOPHARMA INC 0%SNDX : SYNDAX PHARMACEUTICALS INC 2.97%XNCR : XENCOR INC 0%

Definition of Inventory to Assets Ratio

[Calculation] [Inventory] as percentage of total [Assets], serves as an efficiency ratio - the lower the better.
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for NIAGEN BIOSCIENCE INC is calculated as follows: Inventory [ $ 11.03M ] / Assets [ $ 37.41M ]
(=) Inv. to Assets [ 29.48% ]

NAGE - Inventory to Assets Ratio, Last 5 years

13.46%

Minimum

Dec 31, 2024

34.24%

Maximum

Sep 30, 2022

23.31%

Average

22.81%

Median

Inv. to Assets Benchmark Analysis

The chart above depicts the distribution of Inv. to Assets for companies in the Total Stock Market. The average Inv. to Assets of the companies is 6.08% with a standard deviation of 11.11%.
The following table provides additional summary stats:
Inv. to Assets in the Market:
filtered constituents4.46K
min0%
max98.39%
average6.08%
median0%
std11.11%